Abrysvo Interactions
There are 304 drugs known to interact with Abrysvo (rsv vaccine, pref a-pref b, recombinant), along with 2 disease interactions. Of the total drug interactions, 1 is major, 300 are moderate, and 3 are minor.
- View all 304 medications that may interact with Abrysvo
- View Abrysvo disease interactions (2)
Most frequently checked interactions
View interaction reports for Abrysvo (rsv vaccine, pref a-pref b, recombinant) and the medicines listed below.
- acetaminophen
- albuterol
- amlodipine
- aspirin
- Aspirin Low Strength (aspirin)
- atorvastatin
- benzonatate
- calcium / vitamin d
- cephalexin
- Eliquis (apixaban)
- famotidine
- fexofenadine
- Fluzone High-Dose Quadrivalent (influenza virus vaccine, inactivated)
- influenza virus vaccine, inactivated
- losartan
- metformin
- Moderna COVID-19 Vaccine (COVID-19 mRNA (Moderna) vaccine)
- Mucinex (guaifenesin)
- omeprazole
- oxycodone
- Ozempic (semaglutide)
- pantoprazole
- Pfizer-BioNTech COVID-19 Vaccine (COVID-19 mRNA (Pfizer) vaccine)
- Pneumovax 23 (pneumococcal 23-polyvalent vaccine)
- prednisone
- Prevnar 20 (pneumococcal 20-valent conjugate vaccine)
- Shingrix (zoster vaccine, recombinant)
- tramadol
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
Abrysvo disease interactions
There are 2 disease interactions with Abrysvo (rsv vaccine, pref a-pref b, recombinant) which include:
Report options
QR code containing a link to this page
More about Abrysvo (rsv vaccine, pref a-pref b, recombinant)
- Abrysvo consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: viral vaccines
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
